LENZ Therapeutics (LENZ) Preferred Shares Issued (2020 - 2023)

LENZ Therapeutics (LENZ) has 3 years of Preferred Shares Issued data on file, last reported at $17.0 million in Q2 2023.

• Quarterly Preferred Shares Issued changed N/A year-over-year to $17.0 million in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $17.0 million (down 74.28% YoY) and the FY2023 annual result came in at $83.0 million, changed N/A from the prior year.
• Preferred Shares Issued slipped to $17.0 million in Q2 2023 per LENZ's latest filing, from $66.0 million in the prior quarter.
• Across five years, Preferred Shares Issued topped out at $150.7 million in Q1 2021 and bottomed at $10.0 million in Q2 2020.
• The 3-year median for Preferred Shares Issued is $16.0 million (2020), against an average of $45.6 million.
• Peak annual rise in Preferred Shares Issued reached 48.21% in 2021, while the deepest fall reached 48.21% in 2021.
• Tracing LENZ's Preferred Shares Issued over 3 years: stood at $15.0 million in 2020, then dropped by 1.19% to $14.8 million in 2021, then increased by 14.54% to $17.0 million in 2023.
• Per Business Quant, the three latest LENZ Preferred Shares Issued figures stand at $17.0 million (Q2 2023), $66.0 million (Q1 2023), and $14.8 million (Q2 2021).

Peer Comparison